Literature DB >> 31482498

Stability of Therapeutic Enzymes: Challenges and Recent Advances.

Shubhrima Ghosh1, Shahenvaz Alam1, Anurag S Rathore2, S K Khare3.   

Abstract

Enzymes are biocatalysts that have found profound applications in the current biotherapeutic industry and play a crucial role in diagnosis, prevention, and biochemical analysis of major diseases. However, stability, protein degradation and immunogenicity in the body present unique challenges that are faced upon sustained use of such enzymes. The present chapter is an attempt to dissect the state-of-the-art in relation to the challenges of development of therapeutic enzymes and the recent advances to address them. At the very outset, diseases where enzymes have found effective applications and the various causes of enzyme instability have been discussed. In recent times, polymer or nano- conjugated resistant delivery methods, as well as mutagenesis have led to manifold increase in enzyme stability against thermal denaturation, acidic gut environment, proteolysis and immunogenicity. Further, methods of analytical characterization of proteins have been highlighted and explored to shape future research directions.

Entities:  

Keywords:  Enzyme; Immunogenicity; Metabolic disorders; Mutagenesis; Protein denaturation

Mesh:

Substances:

Year:  2019        PMID: 31482498     DOI: 10.1007/978-981-13-7709-9_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  101 in total

Review 1.  DNA topoisomerases as targets for antiprotozoal therapy.

Authors:  R P Bakshi; T A Shapiro
Journal:  Mini Rev Med Chem       Date:  2003-09       Impact factor: 3.862

Review 2.  Enzyme replacement therapy for Pompe disease.

Authors:  Corrado Angelini; Claudio Semplicini
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

3.  Protein structure determination from NMR chemical shifts.

Authors:  Andrea Cavalli; Xavier Salvatella; Christopher M Dobson; Michele Vendruscolo
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

4.  Enzyme replacement therapy for mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): experience in Hong Kong.

Authors:  W M But; M Y Wong; J C K Chow; W K Y Chan; W T Ko; S P Wu; M L Wong; T Y Miu; W Y Tse; W W Y Hung; T W Fan; C C Shek
Journal:  Hong Kong Med J       Date:  2011-08       Impact factor: 2.227

Review 5.  Cultivating the uncultured: limits, advances and future challenges.

Authors:  Karine Alain; Joël Querellou
Journal:  Extremophiles       Date:  2009-06-23       Impact factor: 2.395

Review 6.  Key considerations in the preclinical development of biosimilars.

Authors:  Lynne A Bui; Susan Hurst; Gregory L Finch; Beverly Ingram; Ira A Jacobs; Carol F Kirchhoff; Chee-Keng Ng; Anne M Ryan
Journal:  Drug Discov Today       Date:  2015-04-23       Impact factor: 7.851

Review 7.  Hydrogen bonding in globular proteins.

Authors:  E N Baker; R E Hubbard
Journal:  Prog Biophys Mol Biol       Date:  1984       Impact factor: 3.667

8.  Improved activity and pH stability of E. coli ATCC 11105 penicillin acylase by error-prone PCR.

Authors:  Huseyin Balci; Merve Tuzlakoglu Ozturk; Tjaard Pijning; Saliha Issever Ozturk; Fusun Gumusel
Journal:  Appl Microbiol Biotechnol       Date:  2014-01-05       Impact factor: 4.813

9.  Enzyme replacement therapy for Fabry disease: A systematic review and meta-analysis.

Authors:  Taciane Alegra; Filippo Vairo; Monica V de Souza; Bárbara C Krug; Ida V D Schwartz
Journal:  Genet Mol Biol       Date:  2012-12-18       Impact factor: 1.771

10.  Transmission electron microscopy characterization of fluorescently labelled amyloid β 1-40 and α-synuclein aggregates.

Authors:  Valerie L Anderson; Watt W Webb
Journal:  BMC Biotechnol       Date:  2011-12-19       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.